‘Stunning’ Court Ruling Broadens Hospitals’ 340B Use, Calls HRSA’s Enforcement Authority into Question

A recent federal district court ruling against the office overseeing the 340B Drug Pricing Program has opened the doors for hospitals to more broadly claim discounts, healthcare legal experts say. The decision in Genesis Healthcare, Inc. v. Becerra, handed down Friday by the U.S. District Court of South Carolina, establishes that “at least some of [the] interpretative policies surrounding the 340B definition of patient are inconsistent with the 340B statute,” Anil Shankar, a partner at Foley & Lardner, told Fierce Healthcare. “This is a stunning decision that will have the attention of every 340B stakeholder,” he said. “… This creates new opportunities for 340B-covered entities to purchase 340B for their patients and suggests that [the Health Resources and Services Administration’s (HRSA’s)] audit processes will need to change.”

Read the full article: ‘Stunning’ Court Ruling Broadens Hospitals’ 340B Use, Calls HRSA’s Enforcement Authority into Question //

Source: https://www.fiercehealthcare.com/providers/stunning-court-ruling-broadens-hospitals-340b-use-calls-hrsas-authority-question

Scroll to Top